Received Nov 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | F95YS | — |
Reconstitution of Shingrix with an Unapproved Diluent - Wrong Solution Used; Reconstitution of Shingrix with an Unapproved Diluent - Wrong Solution Used; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate dose of vaccine administered in a 53-year-old patient who received Herpes zoster (Shingrix) (batch number F95YS, expiry date 31-MAR-2027) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate dose of vaccine administered (Verbatim: Reconstitution of Shingrix with an Unapproved Diluent - Wrong Solution Used) and wrong solution used in drug reconstitution (Verbatim: Reconstitution of Shingrix with an Unapproved Diluent - Wrong Solution Used). The outcome of the inappropriate dose of vaccine administered and wrong solution used in drug reconstitution were not applicable. Additional Information: GSK Receipt Date: 21-NOV-2025 The nurse reported that she administered a saline diluent with a Shingrix vaccine and need to know the recommendations. If the patient needs to be revaccinated, the nurse did not use the diluent that comes with the Shingrix vaccine. The vaccine administration facility was the same as primary reporter.